Djoke Hendriks

444 total citations
8 papers, 304 citations indexed

About

Djoke Hendriks is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Djoke Hendriks has authored 8 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Djoke Hendriks's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (2 papers) and Probiotics and Fermented Foods (2 papers). Djoke Hendriks is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (2 papers) and Probiotics and Fermented Foods (2 papers). Djoke Hendriks collaborates with scholars based in Netherlands, United Kingdom and Australia. Djoke Hendriks's co-authors include Auke J. van Heel, Manuel Montalbán‐López, Oscar P. Kuipers, Edwin Bremer, Dongdong Mu, Valerie R. Wiersma, Douwe F. Samplonius, Wijnand Helfrich, Robert J. van Ginkel and Marco de Bruyn and has published in prestigious journals such as European Journal of Cancer, BMC Health Services Research and OncoImmunology.

In The Last Decade

Djoke Hendriks

8 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Djoke Hendriks Netherlands	7	195	92	75	71	47	8	304
Laurence J. Altobell United States	9	238 1.2×	53 0.6×	15 0.2×	46 0.6×	104 2.2×	9	353
Dingka Song China	7	167 0.9×	76 0.8×	20 0.3×	225 3.2×	10 0.2×	15	384
Bianli Gu China	9	171 0.9×	54 0.6×	70 0.9×	54 0.8×	9 0.2×	18	336
Dae Young Kim South Korea	12	219 1.1×	36 0.4×	12 0.2×	57 0.8×	125 2.7×	23	358
Samantha L. Gerlach United States	9	238 1.2×	28 0.3×	18 0.2×	84 1.2×	11 0.2×	14	323
Jonas Steenbrugge Belgium	10	149 0.8×	95 1.0×	7 0.1×	105 1.5×	6 0.1×	17	352
Ute Greczmiel Switzerland	8	152 0.8×	63 0.7×	37 0.5×	145 2.0×	13 0.3×	10	328
Nidia Alvarez-Rueda France	10	185 0.9×	56 0.6×	12 0.2×	89 1.3×	94 2.0×	12	328
Dev Sriranganadane Switzerland	8	120 0.6×	69 0.8×	16 0.2×	84 1.2×	13 0.3×	12	268
Timothy G. Keys Switzerland	10	195 1.0×	20 0.2×	13 0.2×	21 0.3×	64 1.4×	16	289

Countries citing papers authored by Djoke Hendriks

Since Specialization

Citations

This map shows the geographic impact of Djoke Hendriks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Djoke Hendriks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Djoke Hendriks more than expected).

Fields of papers citing papers by Djoke Hendriks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Djoke Hendriks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Djoke Hendriks. The network helps show where Djoke Hendriks may publish in the future.

Co-authorship network of co-authors of Djoke Hendriks

This figure shows the co-authorship network connecting the top 25 collaborators of Djoke Hendriks. A scholar is included among the top collaborators of Djoke Hendriks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Djoke Hendriks. Djoke Hendriks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Peet, Petra G. van, Sarah N. Boers, Monique Tabak, et al.. (2022). Clarifying responsibility: professional digital health in the doctor-patient relationship, recommendations for physicians based on a multi-stakeholder dialogue in the Netherlands. BMC Health Services Research. 22(1). 129–129. 10 indexed citations

Hendriks, Djoke, Douwe F. Samplonius, Robert J. van Ginkel, et al.. (2018). A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint. OncoImmunology. 7(8). e1466016–e1466016. 50 indexed citations

Hendriks, Djoke, Goda Choi, Marco de Bruyn, Valerie R. Wiersma, & Edwin Bremer. (2017). Antibody-Based Cancer Therapy. International review of cell and molecular biology. 331. 289–383. 41 indexed citations

Hendriks, Djoke, Yuan He, Valerie R. Wiersma, et al.. (2016). Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction. OncoImmunology. 5(8). e1202390–e1202390. 36 indexed citations

Hendriks, Djoke, Yi He, Valerie R. Wiersma, et al.. (2016). Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction. European Journal of Cancer. 61. S210–S210. 1 indexed citations

Heel, Auke J. van, Tomas G. Kloosterman, Manuel Montalbán‐López, et al.. (2016). Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery. ACS Synthetic Biology. 5(10). 1146–1154. 69 indexed citations

Wiersma, Valerie R., Marco de Bruyn, Ce Shi, et al.. (2015). C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity. mAbs. 7(2). 321–330. 23 indexed citations

Heel, Auke J. van, Dongdong Mu, Manuel Montalbán‐López, Djoke Hendriks, & Oscar P. Kuipers. (2013). Designing and Producing Modified, New-to-Nature Peptides with Antimicrobial Activity by Use of a Combination of Various Lantibiotic Modification Enzymes. ACS Synthetic Biology. 2(7). 397–404. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact